The Impact of Genome-wide Histocompatibility on Liver Transplantation Outcomes
Authors:
Open Access
- 15 July 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 110 (1) , e175-e184
Abstract
Background.: Liver transplantation (LT) is the standard treatment for end-stage liver diseases. However, the role of HLA matching in LT remains unclear. Immunological allograft injury and rejection are ongoing concerns, particularly when efforts are made to minimize immunosuppression. Although HLA matching currently has no established role in LT, interest in non-HLA compatibility in the field of transplantation is growing. We compared 666 LT recipient-donor pairs and identified amino acid-changing genetic mismatches outside the HLA gene segment in different protein groups and mismatches in 40 common gene deletions. Methods.: We evaluated the association between mismatches and LT outcomes by using adjusted Cox models for missense variant mismatches and deletion analyses. The primary endpoints were acute rejection, late rejection, graft loss, and overall survival. Statistical significance was set at a false discovery rate (FDR) of P = 0.011; FDR P = 0.001; FDR <0.05). Conclusions.: Genome-wide mismatches outside of the HLA region contribute to the risk of LT complications. Robust, large-scale studies are required to validate these results.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Mismatches in Gene Deletions and Kidney-related Proteins as Candidates for Histocompatibility Factors in Kidney TransplantationKidney International Reports, 2022
- Donor–recipient human leukocyte antigen A mismatching is associated with hepatic artery thrombosis, sepsis, graft loss, and reduced survival after liver transplantLiver Transplantation, 2022
- Non-invasive alloimmune risk stratification of long-term liver transplant recipientsJournal of Hepatology, 2021
- Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosisKidney International, 2020
- Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft RejectionLiver Transplantation, 2019
- Human leukocyte antigen, allele, and eplet mismatches in liver transplantation; observations from a small, single center cohortHuman Immunology, 2018
- Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation databaseHepatology, 2008
- HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ, and HLA-DPHuman Immunology, 2007
- The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN databaseLiver Transplantation, 2006
- Banff Schema for Grading Liver Allograft Rejection: An International Consensus DocumentHepatology, 1997